Catalyst Wire Dossier Catalyst Wire Dossier

Difluprednate ophthalmic

Difluprednate · Sandoz Inc
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Difluprednate ophthalmic, covering 2008-06-23 to 2026-08-12. Get the full timeline:

Most recent: FDA Approved: DIFLUPREDNATE OPHTHALMIC — Supplemental Application (Sandoz Inc)

See pricing